{"id":32163,"date":"2020-07-09T12:10:59","date_gmt":"2020-07-09T11:10:59","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32163"},"modified":"2021-11-23T18:12:21","modified_gmt":"2021-11-23T18:12:21","slug":"probiotics-human-skin-microbiome-speakers","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/","title":{"rendered":"Probiotics, Human &#038; Skin Microbiome Speakers"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>\n\tOur <br \/>Speakers (A-Z)\n\t<\/h2>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chris-callewaert\/\" title=\"Chris Callewaert\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery.png\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-315x470.png 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"37021\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chris-callewaert\/chris_callewaert_belgium_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery.png\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-201x300.png\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Chris_Callewaert_Belgium_BioTech_Pharma_Summit_2021_Gallery-686x1024.png\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chris-callewaert\/\" title=\"Chris Callewaert\">\n\t\t\t\t\t\t\tChris Callewaert\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Senior Post-doctoral Researcher at Ghent University, Belgium<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chris-callewaert\/\" title=\"The underarm microbiome and the development of new probiotics\" target=\"_self\" rel=\"noopener\">\n\tThe underarm microbiome and the development of new probiotics\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Dr. Chris Callewaert is senior postdoctoral research fellow of the Research Foundation Flanders (FWO) at Ghent University, Belgium. He studies the skin microbiome and metabolome in health and disease. He is a pioneer in skin microbiome transplantation and skin bacteriotherapy to solve body odor. Since the corona pandemic, he has also been training sniffer dogs to detect COVID19 infection from people&#8217;s sweat, with &gt;95% accuracy.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chrysi-sergaki\/\" title=\"Chrysi Sergaki\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"36358\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chrysi-sergaki\/chrysi-sergaki_nibsc_biotech_pharma_summit_2021_porto_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;4.5&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;NIKON D5100&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1616015829&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;80&quot;,&quot;iso&quot;:&quot;1600&quot;,&quot;shutter_speed&quot;:&quot;0.05&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Chrysi Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/05\/Chrysi-Sergaki_NIBSC_BioTech_Pharma_Summit_2021_Porto_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chrysi-sergaki\/\" title=\"Chrysi Sergaki\">\n\t\t\t\t\t\t\tChrysi Sergaki\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Microbiome Scientist at National Institute for Biological Standards and Control (NIBSC\/MHRA)<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/chrysi-sergaki\/\" title=\"Developing global standards for the microbiome field\" target=\"_self\" rel=\"noopener\">\n\tDeveloping global standards for the microbiome field\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Dr Chrysi Sergaki is a scientist in the Microbiome section at the National Institute for Biological Standards and Control (NIBSC), working on microbial interactions and how to utilise them for the benefit of human health.<\/p>\n<p>At NIBSC, Chrysi is leading projects investigating the role of the microbiome in gut health and disease. Furthermore, she is leading the development of reference reagents that can act as global standards and will be evaluated as candidates for the first World Health Organization Whole Cell Reference Reagents for the microbiome.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/daniel-brownell\/\" title=\"Daniel Brownell\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"37201\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/daniel-brownell\/dan_brownell_aobiome_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Dan_Brownell_Aobiome_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/daniel-brownell\/\" title=\"Daniel Brownell\">\n\t\t\t\t\t\t\tDaniel Brownell\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Director, Research &amp; Development at AOBiome Therapeutics<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/daniel-brownell\/\" title=\"Ammonia Oxidizing Bacteria as a Treatment for Inflammatory Skin Disease\" target=\"_self\" rel=\"noopener\">\n\tAmmonia Oxidizing Bacteria as a Treatment for Inflammatory Skin Disease\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Daniel Brownell currently serve as the Director of R&amp;D at AOBiome, responsible for preclinical research, study execution, and clinical support. Previously, he have served as the Director of R&amp;D and Manufacturing at Sample6, who developed a line of rapid diagnostics for the food safety industry.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/eline-klaassens\/\" title=\"Eline Klaassens\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"36594\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/eline-klaassens\/eline_klaassens_base_clear_biotech_pharma_summit_2021_profile_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;@BasReichert&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/09\/Eline_Klaassens_Base_Clear_BioTech_Pharma_Summit_2021_Profile_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/eline-klaassens\/\" title=\"Eline Klaassens\">\n\t\t\t\t\t\t\tEline Klaassens\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Product Manager Human Health at BaseClear B.V.<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/eline-klaassens\/\" title=\"Path towards products that work in balance with the microbiome\" target=\"_self\" rel=\"noopener\">\n\tPath towards products that work in balance with the microbiome\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Eline is product manager Human Health at BaseClear and specialises in offering expert advice in refining research questions, hypotheses, consultancy in study design including sampling, analysing the microbial data and interpretation of the generated data. Eline has a strong background in human microbiome analysis, holding a PhD degree from Wageningen University in Microbial Eco-physiology of the human intestinal tract.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/george-paraskevakos\/\" title=\"George Paraskevakos\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery.png\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-315x470.png 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"37126\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/george-paraskevakos\/george-paraskevakos_bps_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery.png\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"George Paraskevakos_BPS_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-201x300.png\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/George-Paraskevakos_BPS_2021_Gallery-686x1024.png\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/george-paraskevakos\/\" title=\"George Paraskevakos\">\n\t\t\t\t\t\t\tGeorge Paraskevakos\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Executive Director at International Probiotics Association (IPA)<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/george-paraskevakos\/\" title=\"Microbes and the Skin: Science, Regulation and the Marketplace\" target=\"_self\" rel=\"noopener\">\n\tMicrobes and the Skin: Science, Regulation and the Marketplace\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>George is the executive director of the\u00a0<strong>International Probiotics Association (IPA)<\/strong>. George has been involved with the probiotic industry since 2007 where he served in various roles from business development to account management with a globally recognized probiotic producer. During this time, he also served on the IPA Board of Directors and had two (2) mandates as President before taking on the association&#8217;s leadership role as Executive Director in 2015.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\" title=\"Greg Hillebrand\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"37173\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/greg_hillebrand_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;11&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;Canon EOS 10D&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1380211774&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;44&quot;,&quot;iso&quot;:&quot;100&quot;,&quot;shutter_speed&quot;:&quot;0.008&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\" title=\"Greg Hillebrand\">\n\t\t\t\t\t\t\tGreg Hillebrand\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Senior Principal Research Scientist at Amway<\/h5>\n<h4>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/george-paraskevakos\/\" title=\"Topical rosemary extract containing carnosic acid inhibits Staphylococcus aureus virulence in vitro and reduces the signs and symptoms of adult skin irritation and eczema in a randomized, double-blind, vehicle-controlled pilot study.\" target=\"_self\" rel=\"noopener\">\n\tTopical rosemary extract containing carnosic acid inhibits Staphylococcus aureus virulence in vitro and reduces the signs and symptoms of adult skin irritation and eczema in a randomized, double-blind, vehicle-controlled pilot study.\n\t\t\t<\/a>\n\t<\/h4>\n\t<p>Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company&#8217;s skin and oral microbiome clinical research and product development initiatives.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/jean-pol-warzee\/\" title=\"Jean-Pol Warz\u00e9e\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"32206\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/jean-pol-warzee\/jean-pol-warzee_biotech_pharma_summit_profile\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;4&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;Canon EOS 5D Mark III&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1472638979&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;55&quot;,&quot;iso&quot;:&quot;100&quot;,&quot;shutter_speed&quot;:&quot;0.00625&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Jean-Pol-Warze\u0301e_BioTech_Pharma_Summit_Profile-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/jean-pol-warzee\/\" title=\"Jean-Pol Warz\u00e9e\">\n\t\t\t\t\t\t\tJean-Pol Warz\u00e9e\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>President at European Scientific League for Probiotics &#8211; ESLP<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/jean-pol-warzee\/\" title=\"Quality control of probiotics and internationalisation of the ESLP initiative\" target=\"_self\" rel=\"noopener\">\n\tQuality control of probiotics and internationalisation of the ESLP initiative\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>With more than 20 years experience in the microbiota and microbiotics area, Jean-Pol G. Warz\u00e9e, Medical Doctor has participated to many research and development projects in human health ( by elderly people, cystic fibrosis, &#8230;) and also in animal health in collaboration with Research Centers and Universities. Jean-pol has collaborated to the development of new microbiotics solutions and is author, co-author of many publications.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/lionel-breton\/\" title=\"Lionel Breton\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"32225\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/lionel-breton\/lionel_breton_loreal_biotech_pharma_summit_profile\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1536884242&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Lionel_Breton_Loreal_BioTech_Pharma_Summit_profile-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/lionel-breton\/\" title=\"Lionel Breton\">\n\t\t\t\t\t\t\tLionel Breton\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Cofounder and executive VP of IDEC therapeutics<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/lionel-breton\/\" title=\"Considering the Microbiome Interorgans Axis (MIA) as a future option in Health &amp; Diseases\" target=\"_self\" rel=\"noopener\">\n\tConsidering the Microbiome Interorgans Axis (MIA) as a future option in Health &amp; Diseases\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Lionel Breton got a PhD in 1982 in general Endocrinology in the lab of R.Michel and J.Roche at College de France in Paris. Than, he got a State Doctorate in general Pharmacology in Poitiers Hospital\/ school of medicine in 1985 After a 1st position in Servier Laboratory as Project leader in neuro-pharmacology. He is also visiting Professor\/affiliate member in the prestigious University McGill in Montreal.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\" title=\"Marcus Claesson\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery.png\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-315x470.png 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"36979\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/marcus_claesson_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery.png\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-201x300.png\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-686x1024.png\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\" title=\"Marcus Claesson\">\n\t\t\t\t\t\t\tMarcus Claesson\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Chief Executive Officer at SeqBiome<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\" title=\"Unravelling the microbiome of inflammatory bowel disease\" target=\"_self\" rel=\"noopener\">\n\tUnravelling the microbiome of inflammatory bowel disease\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC) sequencing and comparing commensal Lactobacillus species. This was followed by postdoctoral fellowships mining probiotic bacteria and analysing the microbiomes of older people as part of the ELDERMET project. Marcus is now a PI at APC Microbiome Ireland, UCC, where his main research interests in the role of microbiota in inflammatory bowel disease, and methods development for &#8216;omics&#8217; technologies.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marie-drago\/\" title=\"Marie Drago\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"37190\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marie-drago\/marie_drago_gallinee_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;Adrian Samson&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marie_Drago_Gallinee_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marie-drago\/\" title=\"Marie Drago\">\n\t\t\t\t\t\t\tMarie Drago\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Founder at Gallin\u00e9e<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marie-drago\/\" title=\"Scalp Microbiome, how to develop specific products, and for what results?\" target=\"_self\" rel=\"noopener\">\n\tScalp Microbiome, how to develop specific products, and for what results?\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Marie Drago is a\u00a0Doctor\u00a0in\u00a0Pharmacy\u00a0and the\u00a0founder\u00a0of Gallinee Microbiome Skincare.\u00a0Launched\u00a0in 2016 in London, the brand has been caring for the skin and its microbiome though innovative products across a number of categories.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/momo-vuyisich\/\" title=\"Momo Vuyisich\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"32201\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/momo-vuyisich\/momo_vuyisich_biotech_pharma_summit_viome_1\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;4&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;DSC-RX10M3&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1548237114&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;62.39&quot;,&quot;iso&quot;:&quot;200&quot;,&quot;shutter_speed&quot;:&quot;0.033333333333333&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Momo_Vuyisich_BioTech_Pharma_Summit_Viome_1-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/momo-vuyisich\/\" title=\"Momo Vuyisich\">\n\t\t\t\t\t\t\tMomo Vuyisich\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Founder and Chief Science Officer at Viome<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/momo-vuyisich\/\" title=\"Platform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health\/disease states\" target=\"_self\" rel=\"noopener\">\n\tPlatform that allows to study the connections among diet, gut microbiome, immune system, human physiology, and health\/disease states\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Momo Vuyisich is a founder and Chief Science Officer of Viome. He is also an Adjunct Professor at the University of New Mexico and New Mexico Tech. Besides providing scientific leadership at Viome, Momo focuses on product development, clinical certification, and clinical research.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/newton-gomes\/\" title=\"Newton Gomes\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"36943\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/newton-gomes\/newton_gomes_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;7.1&quot;,&quot;credit&quot;:&quot;Nuno Freire&quot;,&quot;camera&quot;:&quot;Canon EOS 7D Mark II&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1591367264&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;24&quot;,&quot;iso&quot;:&quot;100&quot;,&quot;shutter_speed&quot;:&quot;0.005&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Newton_Gomes_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/newton-gomes\/\" title=\"Newton Gomes\">\n\t\t\t\t\t\t\tNewton Gomes\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Researcher University of Aveiro\/Co-founder at InnerCore Microbiome<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/newton-gomes\/\" title=\"The human microbiome is not an island.\" target=\"_self\" rel=\"noopener\">\n\tThe human microbiome is not an island.\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Newton Gomes is a scientist and entrepreneur who is passionate about linking research on environmental and applied microbiology to technological innovation and entrepreneurship. His professional experience includes 6 years as a researcher at the Julius K\u00fchn-Institut (JKI) (Braunschweig, Germany) and more than 14 years as researcher at the Department of Biology and the Centre for Environmental and Marine Studies (CESAM) (University of Aveiro, Portugal).<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/pavlovic-guillaume\/\" title=\"Pavlovic Guillaume\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"32249\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/pavlovic-guillaume\/pavlovic-guillaume_phenomin_biotech_pharma_summit_2\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;1528108801&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Pavlovic-Guillaume_Phenomin_BioTech_Pharma_Summit_2-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/pavlovic-guillaume\/\" title=\"Pavlovic Guillaume\">\n\t\t\t\t\t\t\tPavlovic Guillaume\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Head of Unit at PHENOMIN-ICS<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/pavlovic-guillaume\/\" title=\"Studying the variability of intestinal microbiome in mice to better understand the Human microbiome\" target=\"_self\" rel=\"noopener\">\n\tStudying the variability of intestinal microbiome in mice to better understand the Human microbiome\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Dr Guillaume Pavlovic is the Head of the mouse and rat model creation core &amp; microbiota service at Institut Clinique de la Souris (ICS) &#8211; PHENOMIN. He direct the generation and validation of genetically rodent mutants and animal model microbiota research. He leads R&amp;D programmes focusing on the development of new tools for genetic engineering and microbiota analyses, and is an expert in genetics and genome editing including the CRISPR\/Cas system.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/sergio-esteban\/\" title=\"Sergio Esteban\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery.jpg\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-315x470.jpg 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"36988\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/sergio-esteban\/sergioesteban_biotech_pharma_summit_2021_gallery\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery.jpg\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;1&quot;}\" data-image-title=\"SergioEsteban_BioTech_Pharma_Summit_2021_Gallery\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-201x300.jpg\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/SergioEsteban_BioTech_Pharma_Summit_2021_Gallery-686x1024.jpg\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/sergio-esteban\/\" title=\"Sergio Esteban\">\n\t\t\t\t\t\t\tSergio Esteban\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Project Manager at Probisearch SLU<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/sergio-esteban\/\" title=\"Fertibiome, a probiotic for couples with infertility problems\" target=\"_self\" rel=\"noopener\">\n\tFertibiome, a probiotic for couples with infertility problems\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Sergio Esteban obtained his Ph.D in Molecular Bioscience from the Universidad Autonoma de Madrid (UAM) in 2018. He has a strong scientific investigation background working with different Researching Groups in the fields of cardiovascular, immune and oncology diseases. Most recently, he has joined to the pharmaceutical industry working as Project Manager at Probisearch. Probisearch is a company born to develop new probiotics for animal and human Health.<\/p>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/veronika-oudova\/\" title=\"Veronika Oudova\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"820\" height=\"1224\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1.png\" alt=\"\" loading=\"lazy\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-315x470.png 315w\" sizes=\"auto, (max-width: 820px) 100vw, 820px\" data-attachment-id=\"32232\" data-permalink=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/veronika-oudova\/veronika_oudova_s_biomedic_gut_week_biotech_pharma_summit_microbiome_skin_profile_1\/\" data-orig-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1.png\" data-orig-size=\"820,1224\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-201x300.png\" data-large-file=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Veronika_Oudova_S_Biomedic_Gut_Week_BioTech_Pharma_Summit_Microbiome_Skin_profile_1-686x1024.png\" \/>\t\t\t\t\t\t\t<\/a>\n\t\t<h4>\n\t\t\t\t\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/veronika-oudova\/\" title=\"Veronika Oudova\">\n\t\t\t\t\t\t\tVeronika Oudova\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\t<h5>Co-founder and Chief Executive Officer at S-Biomedic<\/h5>\n<h3>\n\t\t\t<a href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/veronika-oudova\/\" title=\"S-Biomedic approach of direct skin microbiome modulation\" target=\"_self\" rel=\"noopener\">\n\tS-Biomedic approach of direct skin microbiome modulation\n\t\t\t<\/a>\n\t<\/h3>\n\t<p>Veronika Oudova is a co-founder and Chief Executive Officer of S-Biomedic.<\/p>\n<p>Veronika completed a master study in International Trade in Prague and a master in International Management within the program CEMS located in Prague, Vienna and Rotterdam. After her studies she has worked as project manager and marketing consultant at Cord Blood Bank Czech Republic. There she also co-founded a spin-off company StemCellPro.<\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Our Speakers (A-Z) Chris Callewaert Senior Post-doctoral Researcher at Ghent University, Belgium The underarm microbiome and the development of new probiotics Dr. Chris Callewaert is senior postdoctoral research fellow of the Research Foundation Flanders (FWO) at Ghent University, Belgium. He studies the skin microbiome and metabolome in health and disease. He is a pioneer in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":30835,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-32163","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Probiotics, Human &amp; Skin Microbiome Speakers &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Probiotics, Human &amp; Skin Microbiome Speakers &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Our Speakers (A-Z) Chris Callewaert Senior Post-doctoral Researcher at Ghent University, Belgium The underarm microbiome and the development of new probiotics Dr. Chris Callewaert is senior postdoctoral research fellow of the Research Foundation Flanders (FWO) at Ghent University, Belgium. He studies the skin microbiome and metabolome in health and disease. He is a pioneer in...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-23T18:12:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\",\"name\":\"Probiotics, Human & Skin Microbiome Speakers &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"datePublished\":\"2020-07-09T11:10:59+00:00\",\"dateModified\":\"2021-11-23T18:12:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png\",\"width\":1300,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Probiotics, Human &#038; Skin Microbiome Speakers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Probiotics, Human & Skin Microbiome Speakers &#8226; BioTech Pharma Summit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/","og_locale":"en_US","og_type":"article","og_title":"Probiotics, Human & Skin Microbiome Speakers &#8226; BioTech Pharma Summit","og_description":"Our Speakers (A-Z) Chris Callewaert Senior Post-doctoral Researcher at Ghent University, Belgium The underarm microbiome and the development of new probiotics Dr. Chris Callewaert is senior postdoctoral research fellow of the Research Foundation Flanders (FWO) at Ghent University, Belgium. He studies the skin microbiome and metabolome in health and disease. He is a pioneer in...","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-23T18:12:21+00:00","og_image":[{"width":1300,"height":600,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/","name":"Probiotics, Human & Skin Microbiome Speakers &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","datePublished":"2020-07-09T11:10:59+00:00","dateModified":"2021-11-23T18:12:21+00:00","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/Background_Banner_Logo_BioTech_Pharma_Summit.png","width":1300,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Probiotics, Human &#038; Skin Microbiome Speakers"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=32163"}],"version-history":[{"count":24,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32163\/revisions"}],"predecessor-version":[{"id":37203,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32163\/revisions\/37203"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/30835"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=32163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}